Local administration of activin promotes fracture healing in the rat fibula fracture model

Bone

Volumn 25, Issue 2, 1999, Pages 191-196

  Sakai, R ^a   Miwa, K ^a   Eto, Y ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

Activin; Bone formation; Endochondral bone formation; Fracture healing; Immunohistochemistry; Mechanical strength

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE STRENGTH; CALLUS; ENCHONDRAL OSSIFICATION; FEMALE; FIBULA; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; INTRAARTICULAR DRUG ADMINISTRATION; MECHANICAL STIMULATION; NONHUMAN; RAT;

ACTIVINS; ADMINISTRATION, TOPICAL; ANIMALS; BONE DEVELOPMENT; BONY CALLUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBULA; FRACTURE HEALING; FRACTURES, BONE; GROWTH SUBSTANCES; IMMUNOENZYME TECHNIQUES; INHIBINS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; STRESS, MECHANICAL; TIBIA; TIBIAL FRACTURES; WEIGHT-BEARING;

EID: 0033016747     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00152-0     Document Type: Article

References (36)

1. Beck L.S., Amento E.P., Xu Y., et al. TGF-β induces bone closure of skull defects Temporal dynamics of bone formation in defects exposed to rhTGF-β1 . J Bone Miner Res. 8:1993;753-761.
2. Centrella M., McCarthy T.L., Canalis E. Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone. Mol Cell Biol. 11:1991;250-258.
3. Chapman, M. W. and Woo, S. L.-Y. Principles of Fracture Healing. In: Chapman, M. W., Ed. Operative Orthopaedics; 1983; 115-123.
4. Cheng P., Yu Y.M., Reddi A.H. Chondrogenesis in chick limb bud mesodermal cells Reciprocal modulation by activin and inhibin . Exp Cell Res. 206:1993;119-127.
5. Critchlow M.A., Bland Y.S., Ashhurst D.E. The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2. J Cell Sci. 107:1994;499-516.
6. Esch F.S., Shimasaki S., Cooksey K., et al. Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol Endocrinol. 1:1987;388-396.
7. Eto Y., Tsuji T., Takezawa M., Takano S., Yokogawa Y., Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun. 142:1987;1095-1103.
8. Fleet J.C., Cashman K., Cox K., Rosen V. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology. 137:1996;4605-4610.
9. Fukui A., Nakamura T., Sugino K., et al. Isolation and characterization of Xenopus follistatin and activins. Dev Biol. 159:1993;131-139.
10. Funaba M., Ogawa K., Murata T., et al. Follistatin and activin in bone Expression and localization during endochondral bone development . Endocrinology. 137:1996;4250-4259.
11. Hashimoto M., Shoda A., Inouc S., et al. Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem. 267:1992;4999-5004.
12. Jiang T.X., Yi J.R., Ying S.Y., Chuong C.M. Activin enhances chondrogenesis of limb bud cells Stimulation of precartilaginous mesenchymal condensations and expression of NCAM . Dev Biol. 155:1993;545-557.
13. Joyce M.E., Roberts A.B., Sporn M.B., Bolander M.E. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 110:1990;2195-2207.
14. Kawaguchi H., Kurokawa T., Hanada K., et al. Stimulation of fracture repair by human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology. 135:1994;774-781.
15. Lagna G., Hata A., Hemmati-Brivanlou A., Massagué J. Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature. 383:1996;832-836.
16. Ling N., Ying S.Y., Ueno N., et al. Pituitary FSH is released by a heterodimer of the β subunits from the two forms of inhibin. Nature. 321:1986;779-782.
17. Luyten F.P., Cheng P., Paralkar V., Reddi A.H. Recombinant bone morphogenetic protein-4, transforming growth factor-β1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res. 210:1994;224-229.
18. Massagué J., Andres J., Attisano L., et al. TGF-beta receptors. Mol Reprod Dev. 32:1992;99-104.
19. Matzuk M.M., Kumar T.R., Brandley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 374:1995;356-360.
20. Matzuk M.M., Kumar T.R., Vassalli A., et al. Functional analysis of activin during mammalian development. Nature. 374:1995;354-356.
21. Murata M., Eto Y., Shibai H., Sakai M., Muramatsu M. Erythroid differentiation factor is encoded by the same mRNA as that of inhibin βA chain. Proc Natl Acad Sci USA. 85:1988;2434-2438.
22. Nagamine T., Imamura T., Ishidou Y., et al. Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat. J Orthop Res. 16:1998;314-321.
23. Nielsen H.M., Andreassen T.T., Ledet T., Oxlund H. Local injection of TGF-β increases the strength of tibial fractures in the rat. Acta Orthop Scand. 65:1994;37-41.
24. Noda M., Camilliere J.J. In vivo stimulation of bone formation by transforming growth factor β Endocrinology. 124:1989;2991-2994.
25. Ogawa Y., Schmidt D.K., Nathan R.M., et al. Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J Biol Chem. 267:1992;14233-14237.
26. Oue Y., Kanatani H., Kiyoki M., Eto Y., Ogata E., Matsumoto T. Effect of local injection of activin A on bone formation in newborn rats. Bone. 15:1994;361-366.
27. Reddi A.H. Cell biology and biochemistry of endochondral bone development. Collag Res. 1:1981;209-226.
28. Roberts V.J., Sawchenko P.E., Vale W. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology. 128:1991;3122-3129.
29. Sakurai T., Abe Y., Kasuya Y., et al. Activin A stimulates mitogenesis in Swiss 3T3 fibroblasts without activation of mitogen-activated protein kinases. Biol Chem. 269:1994;14118-14122.
30. Shuto T., Sarkar G., Bronk J.T., Matsui N., Bolander M.E. Osteoblasts express type I and II activin receptors during early intramembranous and endochondral bone formation. J Bone Miner Res. 12:1997;403-411.
31. Si X.H., Jin Y., Yang L.J., Tipoe G.L., White F.H. Expression of BMP-2 and TGF-β1 mRNA during healing of the rabbit mandible. Eur J Oral Sci. 105:1997;325-330.
32. Urist M.R. Bone morphogenetic protein, bone regeneration, heterotopic ossification and the bone-bone marrow consortium. Peck W.A. Bone and Mineral Research. Vol. 6:1989;57-112 Elsevier, New York.
33. Vale W., River J., Vaughan J., et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature. 321:1986;776-779.
34. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation Molecular clones and activities . Science. 242:1988;1528-1534.
35. Yamada R., Suzuki T., Hashimoto M., Eto Y., Shiokawa K., Muramatsu M. Induction of differentiation of human promyelocytic cell line HL-60 by activin/EDF. Biochem Biophys Res Commun. 187:1992;79-85.
36. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2) A radiographic, histological, and biomechanical study in rats . J Bone Jt Surg Am. 74:1992;659-670.